HCV animal models and liver disease

Journal of Hepatology

Volumn 61, Issue 1, 2014, Pages S26-S33

  Vercauteren, Koen ^a   De Jong, Ype P ^b,c   Meuleman, Philip ^a  

^a GHENT UNIVERSITY   (Belgium)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Animal models; Antiviral therapy; Pathology; Viral hepatitis

Indexed keywords

VIRUS PROTEIN; ANTIVIRUS AGENT; VIRUS VACCINE;

ADAPTATION; ARTICLE; CLINICAL RESEARCH; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENCE; IN VIVO STUDY; LIVER DISEASE; NONHUMAN; SCID MOUSE; TRANSGENIC MOUSE; XENOGRAFT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HEPACIVIRUS; LIVER DISEASES; MOUSE; PAN TROGLODYTES; RAT; SCANDENTIA; TRANSGENIC ANIMAL; TREATMENT OUTCOME;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; HETEROGRAFTS; HUMANS; LIVER DISEASES; MICE; PAN TROGLODYTES; RATS; TREATMENT OUTCOME; TUPAIA; VIRAL VACCINES;

EID: 84913554793     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.07.013     Document Type: Review

References (139)

1. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
2. A.A. Kolykhalov, E.V. Agapov, K.J. Blight, K. Mihalik, S.M. Feinstone, and C.M. Rice Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA Science 277 1997 570 574
3. J. Bukh A critical role for the chimpanzee model in the study of hepatitis C Hepatology 39 2004 1469 1475
4. P. Meuleman, and G. Leroux-Roels HCV animal models: a journey of more than 30 years Viruses 1 2009 222 240
5. J. Bukh Animal models for the study of hepatitis C virus infection and related liver disease Gastroenterology 142 2012 e1273
6. V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113
7. K.J. Blight, A.A. Kolykhalov, and C.M. Rice Efficient initiation of HCV RNA replication in cell culture Science 290 2000 1972 1974
8. E. Foy, K. Li, C. Wang, R. Sumpter Jr., M. Ikeda, and S.M. Lemon Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease Science 300 2003 1145 1148
9. E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder, and R. Bartenschlager Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus Nature 437 2005 1167 1172
10. E.D. Brenndorfer, J. Karthe, L. Frelin, P. Cebula, A. Erhardt, and J. Schulte am Esch Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase Hepatology 49 2009 1810 1820
11. T.F. Baumert, J. Vergalla, J. Satoi, M. Thomson, M. Lechmann, and D. Herion Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate Gastroenterology 117 1999 1397 1407
12. B. Bartosch, J. Dubuisson, and F.L. Cosset Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes J Exp Med 197 2003 633 642
13. M. Hsu, J. Zhang, M. Flint, C. Logvinoff, C. Cheng-Mayer, and C.M. Rice Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles Proc Natl Acad Sci U S A 100 2003 7271 7276
14. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, and Z. Zhao Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11 2005 791 796
15. J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, and D.R. Burton Robust hepatitis C virus infection in vitro Proc Natl Acad Sci U S A 102 2005 9294 9299
16. B.D. Lindenbach, M.J. Evans, A.J. Syder, B. Wolk, T.L. Tellinghuisen, and C.C. Liu Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626
17. R. Bartenschlager, V. Lohmann, and F. Penin The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection Nat Rev Microbiol 11 2013 482 496
18. T. Shimakami, C. Welsch, D. Yamane, D.R. McGivern, M. Yi, and S. Zeuzem Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus Gastroenterology 140 2011 667 675
19. Y.P. Li, S. Ramirez, J.M. Gottwein, T.K. Scheel, L. Mikkelsen, and R.H. Purcell Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains Proc Natl Acad Sci U S A 109 2012 E1101 E1110
20. Y.P. Li, S. Ramirez, S.B. Jensen, R.H. Purcell, J.M. Gottwein, and J. Bukh Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system Proc Natl Acad Sci U S A 109 2012 19757 19762
21. T. Date, T. Kato, J. Kato, H. Takahashi, K. Morikawa, and D. Akazawa Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone J Virol 86 2012 10805 10820
22. S. Ramirez, Y.P. Li, S.B. Jensen, J. Pedersen, J.M. Gottwein, and J. Bukh Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors Hepatology 59 2014 395 407
23. E. Steinmann, and T. Pietschmann Cell culture systems for hepatitis C virus Curr Top Microbiol Immunol 369 2013 17 48
24. J.M. Gottwein, and J. Bukh Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems Adv Virus Res 71 2008 51 133
25. K.M. Olsavsky, J.L. Page, M.C. Johnson, H. Zarbl, S.C. Strom, and C.J. Omiecinski Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues Toxicol Appl Pharmacol 222 2007 42 56
26. L. Wang, and J.L. Boyer The maintenance and generation of membrane polarity in hepatocytes Hepatology 39 2004 892 899
27. T. Sheahan, C.T. Jones, and A. Ploss Advances and challenges in studying hepatitis C virus in its native environment Expert Rev Gastroenterol Hepatol 4 2010 541 550
28. P. Podevin, A. Carpentier, V. Pene, L. Aoudjehane, M. Carriere, and S. Zaidi Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes Gastroenterology 139 2010 1355 1364
29. A. Ploss, S.R. Khetani, C.T. Jones, A.J. Syder, K. Trehan, and V.A. Gaysinskaya Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures Proc Natl Acad Sci U S A 107 2010 3141 3145
30. L. Andrus, S. Marukian, C.T. Jones, M.T. Catanese, T.P. Sheahan, and J.W. Schoggins Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells Hepatology 54 2011 1901 1912
31. S. Marukian, L. Andrus, T.P. Sheahan, C.T. Jones, E.D. Charles, and A. Ploss Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures Hepatology 54 2011 1913 1923
32. S. Lagaye, H. Shen, B. Saunier, M. Nascimbeni, J. Gaston, and P. Bourdoncle Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection Hepatology 56 2012 861 872
33. X. Wu, J.M. Robotham, E. Lee, S. Dalton, N.M. Kneteman, and D.M. Gilbert Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation PLoS Pathog 8 2012 e1002617
34. P. Roelandt, S. Obeid, J. Paeshuyse, J. Vanhove, A. Van Lommel, and Y. Nahmias Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus J Hepatol 57 2012 246 251
35. R.E. Schwartz, H.E. Fleming, S.R. Khetani, and S.N. Bhatia Pluripotent stem cell-derived hepatocyte-like cells Biotechnol Adv 32 2014 504 513
36. K. Vercauteren, N. Van Den Eede, A.A. Mesalam, S. Belouzard, M.T. Catanese, and D. Bankwitz Successful anti-SR-BI mAb therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents Hepatology 2014 [Epub ahead of print]. http://dx.doi.org/10.1002/hep.27196
37. D.F. Mercer, D.E. Schiller, J.F. Elliott, D.N. Douglas, C. Hao, and A. Rinfret Hepatitis C virus replication in mice with chimeric human livers Nat Med 7 2001 927 933
38. J. Bukh, T. Pietschmann, V. Lohmann, N. Krieger, K. Faulk, and R.E. Engle Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees Proc Natl Acad Sci U S A 99 2002 14416 14421
39. M. Sourisseau, O. Goldman, W. He, J.L. Gori, H.P. Kiem, and V. Gouon-Evans Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection Gastroenterology 145 2013 e967
40. K. Abe, T. Kurata, Y. Teramoto, J. Shiga, and T. Shikata Lack of susceptibility of various primates and woodchucks to hepatitis C virus J Med Primatol 22 1993 433 434
41. Y. Amako, K. Tsukiyama-Kohara, A. Katsume, Y. Hirata, S. Sekiguchi, and Y. Tobita Pathogenesis of hepatitis C virus infection in Tupaia belangeri J Virol 84 2010 303 311
42. L. Mailly, E. Robinet, P. Meuleman, T.F. Baumert, and M.B. Zeisel Hepatitis C virus infection and related liver disease: the quest for the best animal model Front Microbiol 4 2013 213
43. J. Bitzegeio, D. Bankwitz, K. Hueging, S. Haid, C. Brohm, and M.B. Zeisel Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors PLoS Pathog 6 2010 e1000978
44. A. Ploss, M.J. Evans, V.A. Gaysinskaya, M. Panis, H.N. You, and Y.P. de Jong Human occludin is a hepatitis C virus entry factor required for infection of mouse cells Nature 457 2009 882 886
45. A. Frentzen, Anggakusuma, E. Gurlevik, K. Hueging, S. Knocke, and C. Ginkel Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells Hepatology 59 2014 78 88
46. L. Frelin, E.D. Brenndorfer, G. Ahlen, M. Weiland, C. Hultgren, and M. Alheim The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease Gut 55 2006 1475 1483
47. K. Koike, K. Moriya, K. Ishibashi, Y. Matsuura, T. Suzuki, and I. Saito Expression of hepatitis C virus envelope proteins in transgenic mice J Gen Virol 76 1995 3031 3038
48. T. Kawamura, A. Furusaka, M.J. Koziel, R.T. Chung, T.C. Wang, and E.V. Schmidt Transgenic expression of hepatitis C virus structural proteins in the mouse Hepatology 25 1997 1014 1021
49. C. Pasquinelli, J.M. Shoenberger, J. Chung, K.M. Chang, L.G. Guidotti, and M. Selby Hepatitis C virus core and E2 protein expression in transgenic mice Hepatology 25 1997 719 727
50. K. Moriya, H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Ishibashi, and Y. Matsuura Hepatitis C virus core protein induces hepatic steatosis in transgenic mice J Gen Virol 78 1997 1527 1531
51. K. Moriya, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, and K. Ishibashi The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 1998 1065 1067
52. Y. Kamegaya, Y. Hiasa, L. Zukerberg, N. Fowler, J.T. Blackard, and W. Lin Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis Hepatology 41 2005 660 667
53. M. Majumder, A.K. Ghosh, R. Steele, X.Y. Zhou, N.J. Phillips, and R. Ray Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice Virology 294 2002 94 105
54. S. Sekiguchi, K. Kimura, T. Chiyo, T. Ohtsuki, Y. Tobita, and Y. Tokunaga Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver PLoS One 7 2012 e51656
55. G. Ahlen, J. Nystrom, I. Pult, L. Frelin, C. Hultgren, and M. Sallberg In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes J Infect Dis 192 2005 2112 2116
56. A. Chen, G. Ahlen, E.D. Brenndorfer, A. Brass, F. Holmstrom, and M. Chen Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination J Immunol 186 2011 5107 5118
57. H. Lerat, M. Honda, M.R. Beard, K. Loesch, J. Sun, and Y. Yang Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus Gastroenterology 122 2002 352 365
58. H. Lerat, H.L. Kammoun, I. Hainault, E. Merour, M.R. Higgs, and C. Callens Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice J Biol Chem 284 2009 33466 33474
59. P. Chouteau, N. Defer, A. Florimond, J. Calderaro, M. Higgs, and A. Gaudin Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent J Hepatol 57 2012 499 507
60. M. Dorner, J.A. Horwitz, J.B. Robbins, W.T. Barry, Q. Feng, and K. Mu A genetically humanized mouse model for hepatitis C virus infection Nature 474 2011 208 211
61. E. Giang, M. Dorner, J.C. Prentoe, M. Dreux, M.J. Evans, and J. Bukh Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus Proc Natl Acad Sci U S A 109 2012 6205 6210
62. Anggakusuma, C.C. Colpitts, L.M. Schang, H. Rachmawati, A. Frentzen, and S. Pfaender Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells Gut 63 7 2013 1137 1149
63. A. Frentzen, K. Huging, J. Bitzegeio, M. Friesland, S. Haid, and J. Gentzsch Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines PLoS Pathog 7 2011 e1002029
64. Q. Zhu, J.T. Guo, and C. Seeger Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells J Virol 77 2003 9204 9210
65. S.L. Uprichard, J. Chung, F.V. Chisari, and T. Wakita Replication of a hepatitis C virus replicon clone in mouse cells Virol J 3 2006 89
66. G. Long, M.S. Hiet, M.P. Windisch, J.Y. Lee, V. Lohmann, and R. Bartenschlager Mouse hepatic cells support assembly of infectious hepatitis C virus particles Gastroenterology 141 2011 1057 1066
67. M. Dorner, J.A. Horwitz, B.M. Donovan, R.N. Labitt, W.C. Budell, and T. Friling Completion of the entire hepatitis C virus life cycle in genetically humanized mice Nature 501 2013 237 241
68. M. Dandri, M.R. Burda, E. Torok, J.M. Pollok, A. Iwanska, and G. Sommer Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus Hepatology 33 2001 981 988
69. P. Meuleman, L. Libbrecht, R. De Vos, B. de Hemptinne, K. Gevaert, and J. Vandekerckhove Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera Hepatology 41 2005 847 856
70. H. Azuma, N. Paulk, A. Ranade, C. Dorrell, M. Al-Dhalimy, and E. Ellis Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice Nat Biotechnol 25 2007 903 910
71. K.D. Bissig, T.T. Le, N.B. Woods, and I.M. Verma Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model Proc Natl Acad Sci U S A 104 2007 20507 20511
72. K.D. Bissig, S.F. Wieland, P. Tran, M. Isogawa, T.T. Le, and F.V. Chisari Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment J Clin Invest 120 2010 924 930
73. E.P. Sandgren, R.D. Palmiter, J.L. Heckel, C.C. Daugherty, R.L. Brinster, and J.L. Degen Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene Cell 66 1991 245 256
74. K. Overturf, M. Al-Dhalimy, R. Tanguay, M. Brantly, C.N. Ou, and M. Finegold Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinemia type I Nat Genet 12 1996 266 273
75. N. Fausto Hepatocytes break the rules of senescence in serial transplantation studies. Is there a limit to their replicative capacity? Am J Pathol 151 1997 1187 1189
76. N. Fausto Liver regeneration J Hepatol 32 2000 19 31
77. N. Fausto, J.S. Campbell, and K.J. Riehle Liver regeneration Hepatology 43 2006 S45 S53
78. J.A. Rhim, E.P. Sandgren, R.D. Palmiter, and R.L. Brinster Complete reconstitution of mouse liver with xenogeneic hepatocytes Proc Natl Acad Sci U S A 92 1995 4942 4946
79. M. Dandri, M.R. Burda, A. Gocht, E. Torok, J.M. Pollok, and C.E. Rogler Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation Hepatology 34 2001 824 833
80. P. Meuleman, P. Vanlandschoot, and G. Leroux-Roels A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice Biochem Biophys Res Commun 308 2003 375 378
81. T. Vanwolleghem, L. Libbrecht, B.E. Hansen, I. Desombere, T. Roskams, and P. Meuleman Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice J Hepatol 53 2010 468 476
82. E. Robinet, and T.F. Baumert Host and viral determinants for engraftment of virus permissive human hepatocytes into chimeric immunodeficient mice J Hepatol 53 2010 421 423
83. B.D. Lindenbach, P. Meuleman, A. Ploss, T. Vanwolleghem, A.J. Syder, and J.A. McKeating Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro Proc Natl Acad Sci U S A 103 2006 3805 3809
84. J. Bukh, P. Meuleman, R. Tellier, R.E. Engle, S.M. Feinstone, and G. Eder Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models J Infect Dis 201 2010 1381 1389
85. P. Meuleman, J. Bukh, L. Verhoye, A. Farhoudi, T. Vanwolleghem, and R.Y. Wang In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus Hepatology 53 2011 755 762
86. A. Kaul, I. Woerz, P. Meuleman, G. Leroux-Roels, and R. Bartenschlager Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant J Virol 81 2007 13168 13179
87. N. Vassilaki, P. Friebe, P. Meuleman, S. Kallis, A. Kaul, and G. Paranhos-Baccala Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication J Virol 82 2008 11503 11515
88. M.A. Joyce, K.A. Walters, S.E. Lamb, M.M. Yeh, L.F. Zhu, and N. Kneteman HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice PLoS Pathog 5 2009 e1000291
89. K.A. Walters, A.J. Syder, S.L. Lederer, D.L. Diamond, B. Paeper, and C.M. Rice Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes PLoS Pathog 5 2009 e1000269
90. T. Pietschmann, M. Zayas, P. Meuleman, G. Long, N. Appel, and G. Koutsoudakis Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations PLoS Pathog 5 2009 e1000475
91. S. Fafi-Kremer, I. Fofana, E. Soulier, P. Carolla, P. Meuleman, and G. Leroux-Roels Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation J Exp Med 207 2010 2019 2031
92. J.M. Gottwein, T.B. Jensen, C.K. Mathiesen, P. Meuleman, S.B. Serre, and J.B. Lademann Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A J Virol 85 2011 8913 8928
93. R.J. Brown, N. Hudson, G. Wilson, S.U. Rehman, S. Jabbari, and K. Hu Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host J Virol 86 2012 11956 11966
94. J. Doerrbecker, P. Meuleman, J. Kang, N. Riebesehl, C. Wilhelm, and M. Friesland Thermostability of seven hepatitis C virus genotypes in vitro and in vivo J Viral Hepat 20 2013 478 485
95. R. Singaravelu, R. Chen, R.K. Lyn, D.M. Jones, S. O'Hara, and Y. Rouleau Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis Hepatology 59 2014 98 108
96. T. Vanwolleghem, J. Bukh, P. Meuleman, I. Desombere, J.C. Meunier, and H. Alter Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain Hepatology 47 2008 1846 1855
97. M. Law, T. Maruyama, J. Lewis, E. Giang, A.W. Tarr, and Z. Stamataki Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge Nat Med 14 2008 25 27
98. D. Akazawa, M. Moriyama, H. Yokokawa, N. Omi, N. Watanabe, and T. Date Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice Gastroenterology 145 2013 e441 e444
99. T. Vanwolleghem, P. Meuleman, L. Libbrecht, T. Roskams, R. De Vos, and G. Leroux-Roels Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse Gastroenterology 133 2007 1144 1155
100. P. Meuleman, J. Hesselgesser, M. Paulson, T. Vanwolleghem, I. Desombere, and H. Reiser Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo Hepatology 48 2008 1761 1768
101. N.M. Kneteman, A.Y. Howe, T. Gao, J. Lewis, D. Pevear, and G. Lund HCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus Hepatology 49 2009 745 752
102. P. Meuleman, A. Albecka, S. Belouzard, K. Vercauteren, L. Verhoye, and C. Wychowski Griffithsin has antiviral activity against hepatitis C virus Antimicrob Agents Chemother 55 2011 5159 5167
103. F. Narjes, B. Crescenzi, M. Ferrara, J. Habermann, S. Colarusso, and R. Ferreira Mdel Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase J Med Chem 54 2011 289 301
104. E. Ohara, N. Hiraga, M. Imamura, E. Iwao, N. Kamiya, and I. Yamada Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice J Hepatol 54 2011 872 878
105. P. Meuleman, M.T. Catanese, L. Verhoye, I. Desombere, A. Farhoudi, and C.T. Jones A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo Hepatology 55 2012 364 372
106. K. Lacek, K. Vercauteren, K. Grzyb, M. Naddeo, L. Verhoye, and M.P. Slowikowski Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice J Hepatol 57 2012 17 23
107. E.C. Hsu, B. Hsi, M. Hirota-Tsuchihara, J. Ruland, C. Iorio, and F. Sarangi Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers Nat Biotechnol 21 2003 519 525
108. M. Grompe, S. Lindstedt, M. Al-Dhalimy, N.G. Kennaway, J. Papaconstantinou, and C.A. Torres-Ramos Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinemia type I Nat Genet 10 1995 453 460
109. A. Tesfaye, J. Stift, D. Maric, Q. Cui, H.P. Dienes, and S.M. Feinstone Chimeric mouse model for the infection of hepatitis B and C viruses PLoS One 8 2013 e77298
110. K. Kosaka, N. Hiraga, M. Imamura, S. Yoshimi, E. Murakami, and T. Nakahara A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections Biochem Biophys Res Commun 441 2013 230 235
111. P. Meuleman, L. Libbrecht, S. Wieland, R. De Vos, N. Habib, and A. Kramvis Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus J Virol 80 2006 2797 2807
112. J. Petersen, M. Dandri, W. Mier, M. Lutgehetmann, T. Volz, and F. von Weizsacker Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein Nat Biotechnol 26 2008 335 341
113. P. Meuleman, and G. Leroux-Roels The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV Antiviral Res 80 2008 231 238
114. M. Lutgehetmann, T. Volz, A. Kopke, T. Broja, E. Tigges, and A.W. Lohse In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice Hepatology 52 2010 16 24
115. L. Belloni, L. Allweiss, F. Guerrieri, N. Pediconi, T. Volz, and T. Pollicino IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome J Clin Invest 122 2012 529 537
116. M. Lutgehetmann, L.V. Mancke, T. Volz, M. Helbig, L. Allweiss, and T. Bornscheuer Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation Hepatology 55 2012 685 694
117. T. Volz, M. Lutgehetmann, L. Allweiss, M. Warlich, J. Bierwolf, and J.M. Pollok Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice Antivir Ther 17 2012 623 631
118. J.B. Sacci Jr., U. Alam, D. Douglas, J. Lewis, D.L. Tyrrell, and A.F. Azad Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers Int J Parasitol 36 2006 353 360
119. A.M. Vaughan, S.A. Mikolajczak, E.M. Wilson, M. Grompe, A. Kaushansky, and N. Camargo Complete Plasmodium falciparum liver-stage development in liver-chimeric mice J Clin Invest 122 2012 3618 3628
120. K.M. VanBuskirk, M.T. O'Neill, P. De La Vega, A.G. Maier, U. Krzych, and J. Williams Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design Proc Natl Acad Sci U S A 106 2009 13004 13009
121. M.C. Behet, L. Foquet, G.J. van Gemert, E.M. Bijker, P. Meuleman, and G. Leroux-Roels Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum Malar J 13 2014 136
122. L. Foquet, C.C. Hermsen, G.J. van Gemert, E. Van Braeckel, K.E. Weening, and R. Sauerwein Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection J Clin Invest 124 2014 140 144
123. K. Giersch, M. Helbig, T. Volz, L. Allweiss, L.V. Mancke, and A.W. Lohse Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection J Hepatol 60 2014 538 544
124. L. Lootens, P. Meuleman, O.J. Pozo, P. Van Eenoo, G. Leroux-Roels, and F.T. Delbeke UPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study Clin Chem 55 2009 1783 1793
125. O.J. Pozo, P. Van Eenoo, K. Deventer, L. Lootens, W. Van Thuyne, and M.K. Parr Detection and characterization of a new metabolite of 17alpha-methyltestosterone Drug Metab Dispos 37 2009 2153 2162
126. S.C. Strom, J. Davila, and M. Grompe Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity Methods Mol Biol 640 2010 491 509
127. Cohen J. Toxicology 'Humanized' mouse detects deadly drug side effects Science 344 2014 244 245
128. T.J. Bateman, V.G. Reddy, M. Kakuni, Y. Morikawa, and S. Kumar Application of chimeric mice with humanized liver for study of human-specific drug metabolism Drug Metab Dispos 42 2014 1055 1065
129. D. Xu, T. Nishimura, S. Nishimura, H. Zhang, M. Zheng, and Y.Y. Guo Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing PLoS Med 11 2014 e1001628
130. E.C. Ouyang, C.H. Wu, C. Walton, K. Promrat, and G.Y. Wu Transplantation of human hepatocytes into tolerized genetically immunocompetent rats World J Gastroenterol 7 2001 324 330
131. G.Y. Wu, M. Konishi, C.M. Walton, D. Olive, K. Hayashi, and C.H. Wu A novel immunocompetent rat model of HCV infection and hepatitis Gastroenterology 128 2005 1416 1423
132. T.L. Gutti, J.S. Knibbe, E. Makarov, J. Zhang, G.R. Yannam, and S. Gorantla Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice Am J Pathol 184 2014 101 109
133. M.L. Washburn, M.T. Bility, L. Zhang, G.I. Kovalev, A. Buntzman, and J.A. Frelinger A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease Gastroenterology 140 2011 1334 1344
134. S. Asgari, B. Pournasr, G.H. Salekdeh, A. Ghodsizadeh, M. Ott, and H. Baharvand Induced pluripotent stem cells: a new era for hepatology J Hepatol 53 2010 738 751
135. B. Vandekerckhove, S. Vanhee, S. Van Coppernolle, S. Snauwaert, I. Velghe, and T. Taghon In vitro generation of immune cells from pluripotent stem cells Front Biosci 16 2011 1488 1504
136. J. Bukh, X. Forns, S.U. Emerson, and R.H. Purcell Studies of hepatitis C virus in chimpanzees and their importance for vaccine development Intervirology 44 2001 132 142
137. A. Folgori, S. Capone, L. Ruggeri, A. Meola, E. Sporeno, and B.B. Ercole A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees Nat Med 12 2006 190 197
138. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, and M.E. Munk Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201
139. D.B. Olsen, M.E. Davies, L. Handt, K. Koeplinger, N.R. Zhang, and S.W. Ludmerer Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agents Antimicrob Agents Chemother 55 2011 937 939